Evidence map›Paper›PMID 40586160›Full record

ArticleScience progress

The effect of percutaneous endobiliary radiofrequency ablation on biliary stent patency.

Erbil Arik, Fahrettin Yusuf Altintas, Onur Taydas, Omer Faruk Topaloglu, Ahmet Burak Kara, Mahmut Ciner, Omer Faruk Sevinc, Mustafa Ozdemir, Adem Senturk, Ahmet Tarik Eminler and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Endobiliary radiofrequency ablation for malignant biliary obstruction.Therapeutic advances in gastroenterology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Erbil ArikFaculty of Medicine, Department of Radiology, Marmara University, Istanbul, Turkiye.
Fahrettin Yusuf AltintasFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.
Onur TaydasFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.ORCID 0000-0002-9881-7240
Omer Faruk TopalogluFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.ORCID 0000-0002-2331-1923
Ahmet Burak KaraFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.
Mahmut CinerFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.
Omer Faruk SevincFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.
Mustafa OzdemirFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.ORCID 0000-0002-1934-5346
Adem SenturkFaculty of Medicine, Department of Surgery, Sakarya University, Sakarya, Turkiye.
Ahmet Tarik EminlerFaculty of Medicine, Department of Gastroenterology, Sakarya University, Sakarya, Turkiye.
Mehmet Halil OzturkFaculty of Medicine, Department of Radiology, Sakarya University, Sakarya, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveThis study investigated whether endobiliary radiofrequency ablation (eRFA) performed before stent placement benefited the patency of self-expandable metal stents placed in patients with unresectable malignant biliary obstruction.MethodsThe study included 94 patients with biliary malignancies who underwent percutaneous biliary stent placement. The mean age of the patients was 66.9 ± 10.7 years, with 60 males (63.8%). Forty-five patients (47.9%) underwent eRFA (ELRA

Indexed as

CholestasisRadiofrequency AblationStentsAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeBiliary stentELRAendobiliary radiofrequency ablationmalignant biliary obstruction

Identifiers

PMID40586160
PMCPMC12214368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.